project id: TCGA-SARC; case submitter id: TCGA-DX-A6B9; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.96; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.28; rna integrity number: 8.7; age at index: 45; days to birth: -16561; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1967; age at diagnosis: 16561; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1138.0; icd 10 code: C49.8; last known disease status: not reported; morphology: 8890/3; primary diagnosis: Leiomyosarcoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Overlapping lesion of connective, subcutaneous and other soft tissues; synchronous malignancy: No; tissue or organ of origin: Overlapping lesion of connective, subcutaneous and other soft tissues; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 377; days to sample procurement: 0; initial weight: 1070.0; portion submitter id: TCGA-DX-A6B9-01A-12; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 95.0; percent tumor nuclei: 95.0;